These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 29270765)

  • 21. [Effect of Ronghuang Granule on serum FGF23, FGFRs and Klotho in non-dialysis patients with CKD-MBD and kidney deficiency and damp-heat syndrome].
    Hu S; Wang D; Zhang R; Cao Y; Jin H; Mao Y; Wei L; Ren K; Zhang X; Wang Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Dec; 38(12):1427-1432. PubMed ID: 30613009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic, Environmental, and Disease-Associated Correlates of Vitamin D Status in Children with CKD.
    Doyon A; Schmiedchen B; Sander A; Bayazit A; Duzova A; Canpolat N; Thurn D; Azukaitis K; Anarat A; Bacchetta J; Mir S; Shroff R; Yilmaz E; Candan C; Kemper M; Fischbach M; Cortina G; Klaus G; Wuttke M; Köttgen A; Melk A; Querfeld U; Schaefer F;
    Clin J Am Soc Nephrol; 2016 Jul; 11(7):1145-1153. PubMed ID: 27313313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD).
    Ruospo M; Palmer SC; Natale P; Craig JC; Vecchio M; Elder GJ; Strippoli GF
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD006023. PubMed ID: 30132304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Role of vitamin D in the pathogenesis of chronic kidney disease].
    Cozzolino M; Brunini F; Capone V; Ricca F; Kwaidri Y; Montanari E; Cusi D
    Recenti Prog Med; 2013 Jan; 104(1):33-40. PubMed ID: 23439539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intact fibroblast growth factor 23 levels predict incident cardiovascular event before but not after the start of dialysis.
    Nakano C; Hamano T; Fujii N; Obi Y; Matsui I; Tomida K; Mikami S; Inoue K; Shimomura A; Nagasawa Y; Okada N; Tsubakihara Y; Rakugi H; Isaka Y
    Bone; 2012 Jun; 50(6):1266-74. PubMed ID: 22425694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality.
    Shalhoub V; Shatzen EM; Ward SC; Davis J; Stevens J; Bi V; Renshaw L; Hawkins N; Wang W; Chen C; Tsai MM; Cattley RC; Wronski TJ; Xia X; Li X; Henley C; Eschenberg M; Richards WG
    J Clin Invest; 2012 Jul; 122(7):2543-53. PubMed ID: 22728934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vitamin D Metabolites Before and After Kidney Transplantation in Patients Who Are Anephric.
    Jørgensen HS; de Loor H; Billen J; Peersman N; Vermeersch P; Heijboer AC; Ivison F; Vanderschueren D; Bouillon R; Naesens M; Kuypers D; Evenepoel P
    Am J Kidney Dis; 2024 Oct; 84(4):427-436.e1. PubMed ID: 38796137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Examining the effects of uric acid-lowering on markers vascular of calcification and CKD-MBD; A post-hoc analysis of a randomized clinical trial.
    Andrews ES; Perrenoud L; Nowak KL; You Z; Pasch A; Chonchol M; Kendrick J; Jalal D
    PLoS One; 2018; 13(10):e0205831. PubMed ID: 30356327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Klotho and activin A in kidney injury: plasma Klotho is maintained in unilateral obstruction despite no upregulation of Klotho biosynthesis in the contralateral kidney.
    Nordholm A; Mace ML; Gravesen E; Hofman-Bang J; Morevati M; Olgaard K; Lewin E
    Am J Physiol Renal Physiol; 2018 May; 314(5):F753-F762. PubMed ID: 29187373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survey of attitudes of physicians toward the current evaluation and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
    Souqiyyeh MZ; Shaheen FA
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):93-101. PubMed ID: 20061700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical and biochemical characteristics of predialysis patients in terms of 25 hydroxy vitamin D levels].
    Rodríguez Villarreal I; Ortega O; Gallar P; Sánchez M; Callejas R; Gracia C; García la Calle C; Ortiz M; Herrero JC; Mon C; Oliet A; Vigil A
    Nefrologia; 2011; 31(2):185-91. PubMed ID: 21461012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fractures in patients with CKD-diagnosis, treatment, and prevention: a review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation.
    Pimentel A; Ureña-Torres P; Zillikens MC; Bover J; Cohen-Solal M
    Kidney Int; 2017 Dec; 92(6):1343-1355. PubMed ID: 28964571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longitudinal evaluation of FGF23 changes and mineral metabolism abnormalities in a mouse model of chronic kidney disease.
    Stubbs JR; He N; Idiculla A; Gillihan R; Liu S; David V; Hong Y; Quarles LD
    J Bone Miner Res; 2012 Jan; 27(1):38-46. PubMed ID: 22031097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mineral bone disorders in chronic kidney disease.
    Hou YC; Lu CL; Lu KC
    Nephrology (Carlton); 2018 Oct; 23 Suppl 4():88-94. PubMed ID: 30298663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The intervention effect of zuogui pill on chronic kidney disease-mineral and bone disorder regulatory factor.
    Ma X; He L
    Biomed Pharmacother; 2018 Oct; 106():54-60. PubMed ID: 29957466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kidney bone disease and mortality in CKD: revisiting the role of vitamin D, calcimimetics, alkaline phosphatase, and minerals.
    Kalantar-Zadeh K; Shah A; Duong U; Hechter RC; Dukkipati R; Kovesdy CP
    Kidney Int Suppl; 2010 Aug; (117):S10-21. PubMed ID: 20671739
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the effects of novel vitamin D receptor analog VS-105 and paricalcitol on chronic kidney disease-mineral bone disorder in an experimental model of chronic kidney disease.
    Fujii H; Yonekura Y; Nakai K; Kono K; Goto S; Nishi S
    J Steroid Biochem Mol Biol; 2017 Mar; 167():55-60. PubMed ID: 27818277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitamin D deficiency, endothelial function and bone biomarkers in post-kidney transplantation patients from North India.
    Yadav AK; Tiwana S; Steel M; Ramachandran R; Kaski JC; Jha V; Banerjee D
    Int Urol Nephrol; 2019 Jan; 51(1):181-186. PubMed ID: 30456544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Parathyroid function in chronic kidney disease: role of FGF23-Klotho axis.
    Koizumi M; Komaba H; Fukagawa M
    Contrib Nephrol; 2013; 180():110-23. PubMed ID: 23652554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Effect of Extended Release Niacin on Markers of Mineral Metabolism in CKD.
    Malhotra R; Katz R; Hoofnagle A; Bostom A; Rifkin DE; Mcbride R; Probstfield J; Block G; Ix JH
    Clin J Am Soc Nephrol; 2018 Jan; 13(1):36-44. PubMed ID: 29208626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.